Welcome to our dedicated page for High Tide news (Ticker: HITI), a resource for investors and traders seeking the latest updates and insights on High Tide stock.
High Tide Inc. reports developments tied to its cannabis retail, e-commerce and cannabinoid products businesses. The company operates Canna Cabana stores across several Canadian provinces, uses a discount club retail model, and owns online platforms for consumption accessories and hemp-derived CBD products. News commonly covers store openings, financial results, customer-loyalty activity, and the operating performance of its bricks-and-mortar and e-commerce segments.
High Tide updates also address subsidiaries and international activities, including NuLeaf Naturals in U.S. hemp-derived CBD products and Remexian in Germany. Recurring corporate items include financing arrangements, insider ownership, conference participation, governance matters, and company statements related to the trading of its common shares on Nasdaq, TSXV and other markets.
High Tide (Nasdaq: HITI; TSXV: HITI; FSE: 2LYA) reported the voting results of its August 11, 2026 annual general and special shareholders meeting. All five management nominees — Harkirat (Raj) Grover, Christian Sinclair, Arthur Kwan, Menashe Kestenbaum and Kathleen Skerrett — were elected as directors, each receiving about 97–98% of votes cast.
Shareholders approved fixing the Board at five members (97.92% for), appointing Davidson & Company LLP as auditor for the coming year (99.47% for), and the Amended and Restated Shareholder Rights Plan (91.07% for). The release also reiterates High Tide’s cannabis retail and medical distribution footprint in Canada and Germany.
High Tide (Nasdaq: HITI; TSXV: HITI) closed new senior secured credit facilities with Bank of Montreal totaling C$40 million. The package includes a C$25 million committed revolving credit facility with a three-year maturity and a C$15 million committed delayed-draw term loan intended to refinance existing C$15 million second-lien debentures.
According to High Tide, part of the revolver was used to repay and terminate its prior C$6.0 million senior credit facility with ConnectFirst Credit Union, with remaining capacity available for working capital, corporate purposes, permitted acquisitions and investments. The new facilities are secured by substantially all assets of the company and certain subsidiaries and include customary financial and other covenants.
High Tide (Nasdaq/TSXV: HITI) issued preliminary guidance for its third fiscal quarter ended July 31, 2026, forecasting record revenue of C$195–C$200 million, implying 9–12% sequential and 30–34% year-over-year growth. Expected gross profit is C$51–C$53.5 million, up 5–11% sequential and 27–33% year over year.
Adjusted EBITDA is guided to C$15.2–C$16.5 million, implying 9–19% sequential and 43–55% year-over-year growth. According to High Tide, even the low end of guidance is above the highest current analyst estimate for revenue, gross profit and Adjusted EBITDA. The company also reports a record quarterly distribution of over 10 tonnes of medical cannabis flower via Remexian Pharma in Germany, up 33% sequentially and 60% year over year, and notes a return to positive year-over-year same-store sales growth in its Canadian bricks-and-mortar network in June and July. Full Q3 2026 results are expected on September 14, 2026.
High Tide (Nasdaq/TSXV: HITI) has closed its previously announced acquisition of 100% of J. Supply Holdings, which operates as Northern Helm, adding four retail cannabis stores in Ontario for total consideration of $7.77 million, subject to working capital adjustments.
The acquired stores are located in Bowmanville, Kingston, Courtice and Oshawa, bringing High Tide’s footprint to 228 cannabis retail locations in Canada, including 103 in Ontario. Consideration consisted of $3.06 million in assumed debt at a 2% interest rate, $1.88 million in cash, and $2.83 million paid through 921,486 High Tide shares at a deemed price of $3.067 per share, which are subject to a four‑month‑and‑one‑day hold.
According to High Tide, for the three months ended March 31, 2026, the acquired stores generated annualized revenue of $8.5 million and annualized Adjusted EBITDA of $1.7 million, implying a purchase multiple of 4.5x annualized Adjusted EBITDA. The transaction has received conditional TSX Venture Exchange approval and is awaiting final approval.
High Tide (Nasdaq/TSXV: HITI) announced that its new Canna Cabana retail cannabis store at 4828 Bank Street in Ottawa, Ontario, is expected to begin adult-use cannabis and accessories sales on July 24, 2026. This opening increases High Tide’s footprint to 229 Canna Cabana locations across Canada, including 104 in Ontario. The store is in the rapidly growing Findlay’s Creek suburb within Ottawa’s Gloucester area, positioned in a busy retail corridor serving more than 25,000 residents within a five‑kilometre radius, according to High Tide.
High Tide (Nasdaq/TSXV: HITI) announced that Founder & CEO Raj Grover hosted his fifth Reddit Ask Me Anything with shareholders on July 15, 2026, via the company’s official subreddit, r/HighTideInc. The AMA focused on questions about High Tide’s strategy, operations, and outlook, continuing its practice of direct engagement with retail investors.
According to High Tide, the session followed several recent milestones: release of second quarter fiscal 2026 results, the previously announced acquisition of Northern Helm, approval of C$40 million in new senior credit facilities with BMO, and ongoing expansion of its German medical cannabis business through majority-owned Remexian Pharma. The release also highlights Canna Cabana’s 228 Canadian and 1 international locations, its roughly 12% share of the Canadian retail market, and Remexian’s approximately 14% share of the German medical cannabis market.
High Tide (Nasdaq/TSXV: HITI) approved a Temporary Shareholder Rights Plan and an Amended and Restated Shareholder Rights Plan, both dated June 26, 2026.
The Plans aim to maintain compliance with cannabis laws, protect cannabis licences, and promote fair treatment of shareholders in any unsolicited takeover bid, subject to TSXV and shareholder approvals.
High Tide (NASDAQ/TSXV: HITI) announced that majority-owned German subsidiary Remexian Pharma showcased its exclusive German medical cannabis distribution partnerships at Mary Jane Berlin 2026, held June 11–14 in Berlin.
Remexian highlighted premium Canadian brands and its expanding pharmacy network in Germany's growing medical cannabis market.
High Tide (Nasdaq:HITI) reported record Q2 2026 revenue of $179.3 million, up 30% year over year, marking a fourth straight quarterly high. Gross profit was $48.4 million with an improved 27% gross margin. Adjusted EBITDA reached a record $13.9 million, up 73%.
The company generated $1.5 million in free cash flow and achieved positive net income versus prior losses. German subsidiary Remexian delivered record $31.6 million revenue with 27% margin, while Canna Cabana loyalty membership grew 39% to 2.65 million. High Tide also secured $40 million in senior secured credit facilities from Bank of Montreal.
High Tide (Nasdaq/TSXV:HITI) obtained credit approval from Bank of Montreal for C$40 million in new senior secured credit facilities, which remain subject to customary closing conditions.
The package includes a C$25 million three-year revolving facility and a C$15 million delayed draw term loan to refinance existing debt.